Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye.
Ozdemir O, Bychkovsky BL, Unal B, Onder G, Amanvermez U, Aydin E, Ergun B, Sahin I, Gokbayrak M, Ugurtas C, Koroglu MN, Cakir B, Kalay I, Cine N, Ozbek U, Rana HQ, Hatirnaz Ng O, Agaoglu NB. Ozdemir O, et al. Among authors: bychkovsky bl. Cancers (Basel). 2024 Nov 20;16(22):3876. doi: 10.3390/cancers16223876. Cancers (Basel). 2024. PMID: 39594831 Free PMC article.
Incidence of endometrial cancer in BRCA mutation carriers.
Kotsopoulos J, Lubinski J, Huzarski T, Bychkovsky BL, Moller P, Kim RH, Tung N, Eisen A, Foulkes W, Singer CF, Aeilts A, Neuhausen SL, Bordeleau L, Karlan B, Fruscio R, Eng C, Olopade O, Zakalik D, Couch F, Y Cajal TR, Sun P, Gronwald J, Narod SA. Kotsopoulos J, et al. Among authors: bychkovsky bl. Gynecol Oncol. 2024 Oct;189:148-155. doi: 10.1016/j.ygyno.2024.07.687. Epub 2024 Aug 21. Gynecol Oncol. 2024. PMID: 39173195
Ductal Carcinoma In Situ.
Bychkovsky BL, Myers S, Warren LEG, De Placido P, Parsons HA. Bychkovsky BL, et al. Hematol Oncol Clin North Am. 2024 Aug;38(4):831-849. doi: 10.1016/j.hoc.2024.05.014. Hematol Oncol Clin North Am. 2024. PMID: 38960507 Review.
Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer.
Morganti S, Jin Q, Vincuilla J, Buehler R, Ryan S, Stokes S, Parker T, Mittendorf EA, King TA, Weiss A, Partridge AH, Bychkovsky BL, Curigliano G, Tayob N, Lin NU, Garber JE, Tolaney SM, Lynce F. Morganti S, et al. Among authors: bychkovsky bl. NPJ Breast Cancer. 2024 Apr 16;10(1):28. doi: 10.1038/s41523-024-00632-8. NPJ Breast Cancer. 2024. PMID: 38627457 Free PMC article.
TP53-associated early breast cancer: new observations from a large cohort.
Sandoval RL, Bottosso M, Tianyu L, Polidorio N, Bychkovsky BL, Verret B, Gennari A, Cahill S, Achatz MI, Caron O, Imbert-Bouteille M, Noguès C, Mawell KN, Fortuno C, Spurdle AB, Tayob N, Andre F, Garber JE. Sandoval RL, et al. Among authors: bychkovsky bl. J Natl Cancer Inst. 2024 Aug 1;116(8):1246-1254. doi: 10.1093/jnci/djae074. J Natl Cancer Inst. 2024. PMID: 38569880
34 results